Texas biomedical research institute (BIO) - base - IDIQ for barda biological animal model and MCM development
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75A50122D00020
- Awardee
-
Texas Biomedical Research Institute UEI J4EYPCJDQ1H6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 2 $7,003,380 obligated
Award facts
- Opportunity
-
- BARDA Biological Animal Model and MCM Development Pre-Solicitation · 75A50122R00008 · Posted Dec 1, 2021
- Combined order value
-
- $7,003,380 Current, with exercised options
- $12,279,807 Potential, with all options
- Last date to order 81% complete
- IDV ceiling 7% used
- $100,000,000.00
- Maximum order
- $100,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
Texas Biomedical Research Institute (doing business as Southwest Foundation for Biomedical Research), a non-profit research organization based in San Antonio, Texas, was awarded a $100 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) on September 30, 2022, with an ultimate completion date of September 29, 2027. This single-award, civilian contract without set-aside designation establishes a vehicle for the delivery of biological animal model development and medical countermeasure (MCM) development services in support of ASPR's pandemic preparedness and biomedical research initiatives. The underlying IDIQ contract emerged from a pre-solicitation notice posted in December 2021 seeking capability statements for establishment of a Nonclinical Services Network to support the Biomedical Advanced Research and Development Authority (BARDA). The original solicitation specified three primary capability areas: animal model development and testing for biological agents in accordance with Food and Drug Administration requirements; analytical method development; and safety and toxicity testing to provide fit-for-purpose data to sponsors and regulators. Multiple IDIQ contracts were planned for award in the third quarter of fiscal year 2022 to provide nonclinical development services across these capability areas.
Two substantive delivery orders have been issued under this IDIQ vehicle to date. The first delivery order, BIO-AMT-2301, awarded July 20, 2023, covers IDIQ contract management support activities with a ceiling value of $124,428 and performance period through July 19, 2026. The second and more substantial delivery order, BIO-AMT-2303, awarded September 29, 2023, provides for Good Laboratory Practice natural history studies in non-human primate models of filovirus infection, valued at approximately $11.97 million with completion targeted for June 1, 2026. Both delivery orders are structured as cost-plus fixed fee arrangements and will be performed at the contractor's San Antonio, Texas facility. These delivery orders leverage the institute's operation of the Southwest National Primate Research Center and its established expertise in developing non-human primate models for infectious disease research, thereby supporting ASPR's broader mission of medical countermeasure development and pandemic preparedness through preclinical research capabilities essential for understanding filovirus pathogenesis and informing vaccine and therapeutic development strategies.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| BIO-AMT-2303: GLP natural history studies in NHP models of filovirus infection | Office of the Assistant Secretary for Preparedness and Response | $6,857,765 | |
| BIO-AMT-2301: IDIQ contract management support activities | Office of the Assistant Secretary for Preparedness and Response | $145,615 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $75,000 |
Quick answers
Who was awarded contract 75A50122D00020?
75A50122D00020 was awarded to Texas Biomedical Research Institute by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2022.
How much is contract 75A50122D00020 worth?
Orders under 75A50122D00020 have obligated $7,003,380. Their combined potential value, with all options, is $12,279,807. 75A50122D00020's own ceiling is $100,000,000. A single order can be worth up to $100,000,000.
How many orders have been placed under contract 75A50122D00020?
2 orders have been placed under 75A50122D00020, the latest on September 29, 2023.
Who can order from contract 75A50122D00020?
75A50122D00020 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75A50122D00020 competed?
The extent of competition for 75A50122D00020 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV